Abstract:Background Currently, some studies have demonstrated that miR-34a could serve as a suppressor of several cancers including hepatocellular carcinoma (HCC). Previously, we discovered that miR-34a was downregulated in HCC and involved in the tumorigenesis and progression of HCC; however, the mechanism remains unclear. The purpose of this study was to estimate the expression of miR-34a in HCC by applying the microarray profiles and analyzing the predicted targets of miR-34a and their related biological pathways of HCC. Methods Gene expression omnibus (GEO) datasets were conducted to identify the difference of miR-34a expression between HCC and corresponding normal tissues and to explore its relationship with HCC clinicopathologic features. The natural language processing (NLP), gene ontology (GO), pathway and network analyses were performed to analyze the genes associated with the carcinogenesis and progression of HCC and the targets of miR-34a predicted in silico. In addition, the integrative analysis was performed to explore the targets of miR-34a which were also relevant to HCC. Results The analysis of GEO datasets demonstrated that miR-34a was downregulated in HCC tissues, and no heterogeneity was observed (Std. Mean Difference(SMD) = 0.63, 95% confidence intervals(95%CI):[0.38, 0.88], P < 0.00001; P heterogeneity = 0.08 I 2 = 41%). However, no association was found between the expression value of miR-34a and any clinicopathologic characteristics. In the NLP analysis of HCC, we obtained 25 significant HCC-associated signaling pathways. Besides, we explored 1000 miR-34a-related genes and 5 significant signaling pathways in which CCND1 and Bcl-2 served as necessary hub genes. In the integrative analysis, we found 61 hub genes and 5 significant pathways, including cell cycle, cytokine-cytokine receptor interaction, notching pathway, p53 pathway and focal adhesion, which proposed the relevant functions of miR-34a in HCC. Conclusion Our results may lead researchers to understand the molecular mechanism of miR-34a in the diagnosis, prognosis and therapy of HCC. Therefore, the interaction between miR-34a and its targets may promise better prediction and treatment for HCC. And the experiments in vivo and vitro will be conducted by our group to identify the specific mechanism of miR-34a in the progress and deterioration of HCC.

Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma

Research Progress of MicoRNA in Molecular Targeting Treatment of Hepatocellular Carcinoma

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Diagnostic Significance and Potential Function of Mir-338-5p in Hepatocellular Carcinoma: A Bioinformatics Study with Microarray and RNA Sequencing Data

A Comprehensive Insight into the Clinicopathologic Significance of Mir-144-3p in Hepatocellular Carcinoma

Identification of Mir-101-3p Targets and Functional Features Based on Bioinformatics, Meta-Analysis and Experimental Verification in Hepatocellular Carcinoma.

Mir-346 Suppresses Cell Proliferation Through Smyd3 Dependent Approach in Hepatocellular Carcinoma

Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.

Down-regulation of MiR-365 As a Novel Indicator to Assess the Progression and Metastasis of Hepatocellular Carcinoma

Mir-654-3p Predicts the Prognosis of Hepatocellular Carcinoma and Inhibits the Proliferation, Migration, and Invasion of Cancer Cells

Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma

Utility of Mir‑133a‑3p As a Diagnostic Indicator for Hepatocellular Carcinoma: an Investigation Combined with GEO, TCGA, Meta‑analysis and Bioinformatics.

MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps

MicroRNA-337 Regulates the PI3K/AKT and Wnt/β-catenin Signaling Pathways to Inhibit Hepatocellular Carcinoma Progression by Targeting High-Mobility Group AT-hook 2.